MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejso.2025.109621

Медицинская библиотека · European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2025

Benefits of entecavir therapy in HBV-related hepatocellular carcinoma patients with compensated cirrhosis after hepatectomy: A ten-year retrospective cohort study.

Liu Jian, Bai Shilei, Shi Xintong, Yuan Tao, Yu Yongjin, Lin Jianbo, Dai Chun, Wu Yeye, Cui Longjiu, Zhu Bin, Fu Xiaohui, Wang Kui, Yu Wenlong, Li Jun

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Data on the impact of antiviral therapy(AVT) on the long-term outcomes of hepatitis B virus(HBV)-related hepatocellular carcinoma(HCC) patients with historically-proved cirrhosis after hepatectomy are limited. We aimed to determine the effect of AVT on resected HCC in the background of HBV-related cirrhosis.

MATERIALS AND

METHODS

A total of 1396 patients with HBV-related cirrhotic HCC undergoing curative resection were categorized into AVT and no-AVT groups retrospectively. Recurrence rates were compared, especially according to the initiation time of AVT, virological response, and low HBV levels. Early and late recurrence was stratified by 2 years postoperatively.

RESULTS

The 1-, 3-, 5- and 10-year recurrence rates in AVT group(n = 432) were lower than those in no-AVT group(n = 964, 26 %, 49 %, 65 % and 76 % vs. 29 %, 69 %, 87 % and 92 %,p < 0.001). AVT was an independent factor for late, but not early, recurrence(p < 0.001). The late recurrence rates were similar between patients with only postoperative AVT and those with both pre-and postoperative AVT(p = 0.772). In the AVT group, the late recurrence rates in patients with persistent virological response(PVR) were lower than those in patients with low detectable viral levels(LDV, p = 0.003). Logistic regression analysis showed that the time to virological response(p < 0.001) and HBeAg positivity(p < 0.001) were independently associated with LDV. Patients with spontaneous or treatment-induced undetectable HBV showed the lowest and similar late recurrence rates(p = 0.796). Results were similar in multiple sensitivity analyses.

CONCLUSION

Long-term AVT, regardless of preoperative or postoperative initiation, reduced post-resection late recurrence in patients with HCC and cirrhosis, especially in those with PVR.

Для цитирования: Liu Jian, Bai Shilei, Shi Xintong, Yuan Tao, Yu Yongjin, Lin Jianbo, Dai Chun, Wu Yeye, Cui Longjiu, Zhu Bin, Fu Xiaohui, Wang Kui, Yu Wenlong, Li Jun. Benefits of entecavir therapy in HBV-related hepatocellular carcinoma patients with compensated cirrhosis after hepatectomy: A ten-year retrospective cohort study.. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2025. DOI: 10.1016/j.ejso.2025.109621.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.